Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8925904rdf:typepubmed:Citationlld:pubmed
pubmed-article:8925904lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C1367578lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0600139lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0002844lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0162493lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C2677316lld:lifeskim
pubmed-article:8925904lifeskim:mentionsumls-concept:C1508748lld:lifeskim
pubmed-article:8925904pubmed:issue3lld:pubmed
pubmed-article:8925904pubmed:dateCreated1996-11-14lld:pubmed
pubmed-article:8925904pubmed:abstractTextA theoretical pathway of transcriptional regulation of the androgen receptor (AR) gene is via a cAMP response element (CRE) present in its promoter region (-508 to -501). After 20 h of stimulation with 8-bromo-cAMP, AR mRNA was upregulated in LNCaP but not in either PC-3 or DU-145 cell lines. We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB. The ability to regulate AR gene transcription via the second messenger pathway is lost in the PC-3 and DU-145 cell lines. This may be an important primary mechanism of androgen insensitivity in prostate cancer.lld:pubmed
pubmed-article:8925904pubmed:languageenglld:pubmed
pubmed-article:8925904pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8925904pubmed:citationSubsetIMlld:pubmed
pubmed-article:8925904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8925904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8925904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8925904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8925904pubmed:statusMEDLINElld:pubmed
pubmed-article:8925904pubmed:monthAprlld:pubmed
pubmed-article:8925904pubmed:issn0014-5793lld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:AbelPPlld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:WaxmanJJlld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:LalaniE NENlld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:StampG WGWlld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:StubbsA PAPlld:pubmed
pubmed-article:8925904pubmed:authorpubmed-author:HurstHHlld:pubmed
pubmed-article:8925904pubmed:issnTypePrintlld:pubmed
pubmed-article:8925904pubmed:day1lld:pubmed
pubmed-article:8925904pubmed:volume383lld:pubmed
pubmed-article:8925904pubmed:ownerNLMlld:pubmed
pubmed-article:8925904pubmed:authorsCompleteYlld:pubmed
pubmed-article:8925904pubmed:pagination237-40lld:pubmed
pubmed-article:8925904pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:meshHeadingpubmed-meshheading:8925904-...lld:pubmed
pubmed-article:8925904pubmed:year1996lld:pubmed
pubmed-article:8925904pubmed:articleTitleSecond messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145.lld:pubmed
pubmed-article:8925904pubmed:affiliationDepartment of Histopathology, Royal Postgraduate Medical School Hammersmith Hospital, London, UK.lld:pubmed
pubmed-article:8925904pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8925904pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8925904pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8925904lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8925904lld:pubmed